Literature DB >> 17216123

Can late gadolinium enhancement by cardiovascular magnetic resonance identify coronary artery disease as the etiology of new onset congestive heart failure?

Brian J Schietinger1, Szilard Voros, David C Isbell, Craig H Meyer, John M Christopher, Christopher M Kramer.   

Abstract

BACKGROUND: New left ventricular systolic dysfunction affects 500,000 Americans and coronary artery disease (CAD) is responsible for two-thirds of cases. Identifying CAD has both prognostic and therapeutic implications. We evaluated the ability of late gadolinium enhancement (LGE) by cardiovascular magnetic resonance imaging (CMR) to detect CAD as the etiology of recent onset congestive heart failure (CHF).
METHODS: CMR and LGE were performed in 26 patients with new onset left ventricular systolic dysfunction. All patients received an x-ray angiography for identification of CAD. Patients with an acute coronary syndrome with troponin I > 1.0 ng/ml or a history of CAD were excluded. The presence and distribution of LGE was evaluated.
RESULTS: Significant coronary stenoses were present in 5 of 26 patients (19%). LGE in an infarct pattern was found in 2 of the 5 patients with CAD. Of the 21 patients without CAD, 2 had midwall enhancement but none had evidence of LGE in an infarct pattern.
CONCLUSIONS: When present, LGE in an infarct pattern suggests CAD as the etiology of new onset CHF. However, the absence of LGE does not exclude CAD as the underlying etiology. A small proportion of patients with a nonischemic cause of new onset CHF have LGE limited to the midwall.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17216123      PMCID: PMC2955991          DOI: 10.1007/s10554-006-9200-x

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  35 in total

1.  ABNORMAL Q WAVES SIMULATING MYOCARDIAL INFARCTION IN DIFFUSE MYOCARDIAL DISEASES.

Authors:  M E TAVEL; C FISCH
Journal:  Am Heart J       Date:  1964-10       Impact factor: 4.749

Review 2.  Cardiovascular magnetic resonance: structure, function, perfusion, and viability.

Authors:  David C Isbell; Christopher M Kramer
Journal:  J Nucl Cardiol       Date:  2005 May-Jun       Impact factor: 5.952

3.  Positron emission tomography is a useful tool in differentiating idiopathic from ischemic dilated cardiomyopathy.

Authors:  G M Boff; P Zanco; P Della Valentina; P Cardaioli; G Thiene; R Chioin; S Dalla Volta
Journal:  Int J Cardiol       Date:  2000-06-12       Impact factor: 4.164

4.  Myocardial contrast echocardiography for distinguishing ischemic from nonischemic first-onset acute heart failure: insights into the mechanism of acute heart failure.

Authors:  Roxy Senior; Raj Janardhanan; Paramjit Jeetley; Leah Burden
Journal:  Circulation       Date:  2005-09-06       Impact factor: 29.690

5.  Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction.

Authors:  E Wu; R M Judd; J D Vargas; F J Klocke; R O Bonow; R J Kim
Journal:  Lancet       Date:  2001-01-06       Impact factor: 79.321

6.  Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches.

Authors:  Hassan Abdel-Aty; Philipp Boyé; Anja Zagrosek; Ralf Wassmuth; Andreas Kumar; Daniel Messroghli; Petra Bock; Rainer Dietz; Matthias G Friedrich; Jeanette Schulz-Menger
Journal:  J Am Coll Cardiol       Date:  2005-06-07       Impact factor: 24.094

7.  Noninvasive diagnosis of coronary artery disease in patients with heart failure and systolic dysfunction of uncertain etiology, using late gadolinium-enhanced cardiovascular magnetic resonance.

Authors:  Carlos J Soriano; Francisco Ridocci; Jordi Estornell; Javier Jimenez; Vicente Martinez; José A De Velasco
Journal:  J Am Coll Cardiol       Date:  2005-03-01       Impact factor: 24.094

8.  Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography.

Authors:  J J Bax; D Poldermans; A Elhendy; J H Cornel; E Boersma; R Rambaldi; J R Roelandt; P M Fioretti
Journal:  J Am Coll Cardiol       Date:  1999-07       Impact factor: 24.094

9.  Retrospective determination of the area at risk for reperfused acute myocardial infarction with T2-weighted cardiac magnetic resonance imaging: histopathological and displacement encoding with stimulated echoes (DENSE) functional validations.

Authors:  Anthony H Aletras; Gauri S Tilak; Alex Natanzon; Li-Yueh Hsu; Felix M Gonzalez; Robert F Hoyt; Andrew E Arai
Journal:  Circulation       Date:  2006-04-10       Impact factor: 29.690

10.  The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction.

Authors:  R J Kim; E Wu; A Rafael; E L Chen; M A Parker; O Simonetti; F J Klocke; R O Bonow; R M Judd
Journal:  N Engl J Med       Date:  2000-11-16       Impact factor: 91.245

View more
  4 in total

Review 1.  Late gadolinium-enhanced cardiac magnetic resonance.

Authors:  David Lin; Christopher M Kramer
Journal:  Curr Cardiol Rep       Date:  2008-02       Impact factor: 2.931

Review 2.  Korean Guidelines for Diagnosis and Management of Chronic Heart Failure.

Authors:  Min-Seok Kim; Ju-Hee Lee; Eung Ju Kim; Dae-Gyun Park; Sung-Ji Park; Jin Joo Park; Mi-Seung Shin; Byung Su Yoo; Jong-Chan Youn; Sang Eun Lee; Sang Hyun Ihm; Se Yong Jang; Sang-Ho Jo; Jae Yeong Cho; Hyun-Jai Cho; Seonghoon Choi; Jin-Oh Choi; Seong Woo Han; Kyung Kuk Hwang; Eun Seok Jeon; Myeong-Chan Cho; Shung Chull Chae; Dong-Ju Choi
Journal:  Korean Circ J       Date:  2017-09-18       Impact factor: 3.243

Review 3.  Heart failure in patients with normal coronary anatomy: diagnostic algorithm and disease pattern of various etiologies as defined by cardiac MRI.

Authors:  Ralf Wassmuth
Journal:  Cardiovasc Diagn Ther       Date:  2012-06

4.  3.0 T cardiovascular magnetic resonance in patients treated with coronary stenting for myocardial infarction: evaluation of short term safety and image quality.

Authors:  Robin Nijveldt; Alexander Hirsch; Mark B M Hofman; Aernout M Beek; Anje M Spijkerboer; Jan J Piek; Albert C van Rossum
Journal:  Int J Cardiovasc Imaging       Date:  2007-09-06       Impact factor: 2.357

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.